Event Chronicle

Scientific and Practical Master Class

Scientific and Practical Master Class "Opening New Horizons: Challenges, Perspectives, and Innovations in Infertility Treatment". Organized by the International Foundation of Reproductive Medicine alongside the "Mother and Child" Medical Center, the event brought together more than 300 reproductive clinicians, embryologists, geneticists, and gynecologists. Presentations centered on advanced stimulation protocols, preimplantation genetic screening, challenging clinical scenarios, and national reimbursement programs for ART. STOIK COMPANY LLC supported the conference as an official partner. Engaging on-site with department heads and practitioners enabled our team to evaluate current laboratory supply requirements and strengthen partnerships with medical centers across Ukraine.

UARM 2025

Commemorating the 20th anniversary of the Ukrainian Association of Reproductive Medicine (UARM), the symposium gathered leading national reproductive specialists, embryologists, geneticists, and gynecologists. The scientific program featured plenary lectures, panel debates, and complex clinical case reviews covering recurrent ART failures, preimplantation genetic testing, fertility preservation during wartime, and laboratory culture optimization. For our team, attending the annual UARM symposium has long been an essential commitment on our professional calendar. This collaborative setting offered a prime opportunity to communicate directly with our long-standing clients, discuss their daily clinical needs, and gain firsthand insights into laboratory workflow demands. Through on-site discussions, we also established valuable new partnerships with regional clinics and ART centers. Engaging directly within the UARM community helps us closely align with domestic industry priorities and consistently support medical teams with reliable solutions.

Scientific and Practical Master Class

Scientific and Practical Master Class "Opening New Horizons: Issues of Oncofertility in Reproductology". The event focused on fertility preservation for patients with cancer, covering urgent stimulation protocols and the cryopreservation of gametes and tissue. Clinicians reviewed practical cases, oncologist-reproductologist workflows, and the legal aspects of oncofertility. STOIK COMPANY LLC supported the master class as an official partner. It was an opportunity to back an important medical initiative, connect with peers, and discuss day-to-day practitioner needs directly.

ESHRE 2025

The congress in Paris centered on three key areas: the clinical application of artificial intelligence for embryo evaluation, advancements in non-invasive preimplantation genetic testing (niPGT), and the refinement of culture protocols. The professional community addressed personalized approaches for complex clinical cases alongside updated international standards for laboratory safety. For our team, attending ESHRE has long been a key tradition, as it is the premier platform where global specialists gather and unveil the industry's latest developments. During the event, our representatives reviewed manufacturer premieres firsthand and evaluated next-generation laboratory systems. On the exhibition floor, we held productive discussions to secure direct supplies of advanced solutions to Ukraine. These efforts ensured that local clinics and embryology laboratories gained prompt access to cutting-edge ART technologies.

UARM 2024

The symposium focused primarily on the operational challenges clinics face during wartime: gamete preservation, laboratory security, and managing recurrent ART failures. Representatives of STOIK COMPANY LLC attended the event as regular participants. The open setting enabled direct, in-person discussions with embryologists, reproductive clinicians, and medical center owners. We addressed practical supply needs, ongoing logistical constraints, and the most critical product requirements for Ukrainian laboratories today.

ESHRE 2024

The 40th ESHRE Annual Meeting focused on artificial intelligence in embryology, advancements in PGT-A genetic screening, and refined methods for gamete assessment. Discussions centered on improving ART clinical outcomes and the long-term safety of treatments. For STOIK COMPANY LLC, attending the congress each year is a vital tradition that keeps us aligned with the global reproductive community. At the exhibition, our team reviewed the latest manufacturer updates and held supplier talks to maintain uninterrupted access to cutting-edge equipment and consumables in Ukraine. These ongoing partnerships help us deliver dependable, modern laboratory solutions to local fertility clinics.

UARM 2023

The symposium was the first major in-person gathering for Ukrainian reproductive specialists and embryologists since the start of the full-scale war. Key topics included wartime clinic operations, fertility preservation for military personnel, cryostorage safety, and managing recurrent ART failures. Representatives of STOIK COMPANY LLC joined the event as attendees. Alongside laboratory heads and clinic directors, we discussed pressing operational needs amid power grid instability. Maintaining warehouse inventory for 2–3 months of continuous operation and promptly restructuring shipping routes allowed us to prevent delivery bottlenecks and ensure on-time supplies for every partner clinic.

ESHRE 2023

The 39th ESHRE Annual Meeting centered on non-invasive genetic testing (niPGT), artificial intelligence applications in the lab, and lifestyle factors in fertility care. Presentations covered donor safety, advances in cryopreservation, and controlling microenvironmental stress during embryo culture. Representatives of STOIK COMPANY LLC attended the meeting as regular participants. We met with international manufacturing partners on the exhibition floor, reviewed updated laboratory product lines, and secured reliable supply channels for Ukrainian clinics.

ESHRE 2022

The congress was highlighted by updated clinical guidelines on endometriosis and a return to in-person meetings. Scientific sessions focused on gamete selection, extended embryo culture safety, and genetic screening. Despite the outbreak of the full-scale war and severe travel disruption, representatives of STOIK COMPANY LLC participated in the congress. Direct talks with European manufacturers helped reroute deliveries into Ukraine and maintain a steady supply of culture media, labware, and consumables for fertility centers.

UARM 2019

The symposium program centered on personalized controlled stimulation protocols, the role of PGT in cycle efficiency, and clinical strategies for poor ovarian responders. Specialized sessions addressed gamete micromanipulation and quality control in the embryology laboratory. The STOIK COMPANY LLC team joined the meeting as regular delegates. During session breaks, we connected with clinicians and ART department heads to gather direct feedback on the performance of aspiration needles, embryo transfer catheters, and labware turnover, helping us align inventory orders with current clinical demands.

ESHRE 2019

The 35th ESHRE Annual Meeting focused on AI-driven embryo assessment, updated guidelines for embryo biopsy in PGT cycles, and the clinical outcomes of "freeze-all" strategies. Sessions also addressed methods for reducing cellular stress across all stages of in vitro culture. Representatives of STOIK COMPANY LLC attended the meeting as regular participants. In addition to partner meetings, our team joined on-site workshops and product demonstrations hosted by manufacturers. This hands-on format allowed us to inspect updated labware, evaluate culture media performance, and coordinate with Cook Medical representatives to maintain steady deliveries of proven ovum aspiration needles and embryo transfer catheters to Ukrainian clinics.

UARM 2018

The symposium focused on advanced maternal age management, severe male factor infertility, trophectoderm biopsy techniques, and updated cryopreservation protocols. Representatives of STOIK COMPANY LLC attended as participants. We met with reproductive specialists and embryologists to collect post-market surveillance feedback on the consumables and equipment we supply in Ukraine. This direct feedback helps us not only adjust current orders but also maintain a dependable 3-to-5-month safety stock of essential laboratory supplies in our warehouse.

ESHRE 2018

The meeting featured updated clinical guidelines on recurrent pregnancy loss, alongside discussions on embryonic mosaicism and frozen embryo transfer outcomes. Specialists shared practical insights on single embryo transfers and endometrial preparation. Representatives of STOIK COMPANY LLC attended the event as participants. The visit allowed our team to see global innovations firsthand, assess which new equipment and consumables would benefit Ukrainian laboratories, and coordinate directly with international partners to ensure steady inventory stock.

UARM 2017

Scientific presentations centered on strategies for recurrent implantation failure, fertility preservation in patients with cancer, and clinical management of poor ovarian responders. The embryology sessions focused on sperm preparation techniques for severe male factor infertility, gamete selection criteria, and cryopreservation protocols. Representatives of STOIK COMPANY LLC attended the symposium as regular delegates. Meeting directly with embryologists and clinic heads allowed us to clarify laboratory requirements for specific batches of culture media and specialized labware for gamete and embryo handling, ensuring delivery schedules match each clinic's practical workload.

ESHRE 2017

The meeting was marked by the presentation of the benchmark ESHRE Guideline for Good Practice in ART Laboratories. Key scientific sessions focused on morphokinetic embryo selection criteria, the safety of oocyte vitrification, and the optimization of gas phases in benchtop incubation. Representatives of STOIK COMPANY LLC attended the congress as regular participants. Our team reviewed updated physical standards for embryology workstations, evaluated newly exhibited labware and culture media lines, and held direct discussions with European manufacturers to expand the product portfolio available to Ukrainian fertility clinics.

UARM 2016

The scientific program of the symposium covered age-related infertility management, ovarian hyperstimulation syndrome prevention, and frozen embryo transfer optimization. Embryology sessions centered on culture system selection, micromanipulation techniques in severe male factor cases, and viable gamete selection methods. Representatives of STOIK COMPANY LLC attended the event as regular delegates. During a period of active clinical expansion across Ukraine, face-to-face meetings with clinic directors and laboratory specialists were essential. This dialogue provided firsthand insights into daily procedural nuances, practical tool ergonomics, and current clinic workloads, enabling us to maintain adequate safety stock in our warehouse for uninterrupted laboratory operations.

ESHRE 2016

The meeting centered on the shift toward more accurate NGS-based embryo genetic screening and early attempts to analyze DNA directly from spent culture media. Specialists also reviewed outcomes of "freeze-all" strategies and optimal conditions for blastocyst development under low-oxygen incubation. Representatives of STOIK COMPANY LLC attended as regular participants. Each year, this international platform serves as a hub for direct dialogue with manufacturing partners to review emerging products and establish new supply chain arrangements. Furthermore, company representatives observed practical hands-on workshops where Ukrainian embryologists worked with newly formulated media and consumables, evaluating their handling characteristics for routine lab practice.

UARM 2015

The anniversary symposium centered on the adoption of total cycle segmentation ("freeze-all") protocols, embryo banking, and elective single embryo transfer (eSET) supported by Time-lapse technology. Dedicated embryology sessions and specialized workshops addressed comparative genomic hybridization for recurrent implantation failure, biopsy techniques at cleavage versus blastocyst stages, and fertility preservation in patients with cancer. Representatives of STOIK COMPANY LLC attended the meeting as regular delegates. Connecting directly with embryologists and fertility specialists helped our team understand laboratory workflows under expanding genetic screening protocols, evaluate operational requirements for biopsy micromanipulation tools, and align warehouse inventories with the immediate clinical needs of specialists.

ESHRE 2015

The 31st ESHRE Annual Meeting focused on moving away from standardized treatment protocols toward individualized patient management. Key scientific tracks addressed recurrent implantation failure, fine-tuning the in vitro culture environment, and advanced sperm selection strategies prior to micromanipulation. Representatives of STOIK COMPANY LLC attended the meeting as participants. On the exhibition floor, our team closely evaluated leading global manufacturers of culture media, specialized labware, and consumables, reviewing their technical specifications for future dialogue and direct cooperation. These exploratory meetings helped identify the product portfolios best suited to the evolving needs of Ukrainian embryology laboratories.

UARM 2014

Our team at STOIK COMPANY LLC joined the annual UARM symposium, hosted this time in the scenic setting of Pushcha-Vodytsya near Kyiv. The scientific agenda was packed with discussions on complex clinical cases, individualized stimulation protocols, and strategies for overcoming recurrent IVF failures. For our team, the embryology tracks were particularly valuable: colleagues shared practical insights on extended blastocyst culture parameters, subtle nuances of vitrification protocols, and initial experiences with preimplantation genetic screening. Between presentations, we spent extensive time speaking directly with practicing embryologists and laboratory heads — discussing practical outcomes with various lines of culture media and labware, hearing about daily procedural nuances, and noting which consumables are most critical to keep consistently stocked in our warehouse.

UARM 2013

The meeting in Lviv brought specialists together around central clinical challenges: minimizing ovarian stimulation risks, managing poor responders, and exploring new therapeutic pathways for severe male factor infertility. Laboratory discussions emphasized ultra-rapid cryopreservation workflows, morphological assessment criteria, and precise control of gas concentration and temperature across the working area. Delegates from STOIK COMPANY LLC attended the symposium as participants. Face-to-face exchanges with clinicians and embryologists provided a comprehensive view of routine clinic protocols, highlighted practical handling requirements for procedure tools, and helped establish the core inventory items essential for uninterrupted delivery to Ukrainian IVF centers.